Why it matters
Without AI, culture interpretation can be slow or inconsistent, risking inappropriate antimicrobial choices, delays in discharge, and missed stewardship opportunities due to manual data gaps and fragmented records.
From design to safety
Design
AI-supported data design for cultures
Define data interfaces, standardised culture result fields, and antibiotic panels to ensure consistent AI interpretation and reporting pathways; establish data dictionaries, unit conventions, and result codings for organisms and MIC readings.
- MALDI-TOF mass spectrometer
- Automated susceptibility testing instrument
- Blood culture incubator
- LIS (Laboratory Information System)
Build
Build data pipelines and validation
Integrate LIS feeds, ensure feed completeness, and validate ML rules against reference panels and historical results; set version controls and rollback plans for updates.
- LIS (Laboratory Information System)
- MALDI-TOF mass spectrometer
Operation
Real-time culture interpretation and report
AI reads culture results, detects resistance patterns, recommends panels, and generates actionable reports linked to case files; ensure continuity with case discharge and referral letters.
- Automated susceptibility testing instrument
- MIC microdilution panels
- LIS (Laboratory Information System)
- Biosafety cabinet Class II
Maintenance
Ongoing QC and drift monitoring
Regular calibration, proficiency testing, and rule re-validation to prevent drift and maintain accuracy of predictions, with nightly checks and quarterly external quality assessment participation.
- Blood culture incubator
- MALDI-TOF mass spectrometer
- MIC microdilution panels
- LIS (Laboratory Information System)
Safety
Safety governance and compliance checks
Align AI workflows with local rules, radiation and infection control standards, and controlled drug handling for antimicrobial decisions; maintain audit trails for all decisions and approvals.
- Biosafety cabinet Class II
- LIS (Laboratory Information System)
Part by part
- 1
Blood culture incubator
- Watch for
- Failure to maintain set temperatures or sensor drift leading to false-negative culture growth signals.
- AI action
- AI detects temperature excursions and flags potential false results for manual review.
- 2
MALDI-TOF mass spectrometer
- Watch for
- Calibration drift causing misidentification of organisms or incorrect spectral matches.
- AI action
- AI flags out-of-tolerance spectra and requests recalibration or retest.
- 3
Automated susceptibility testing instrument
- Watch for
- Tablet or cartridge readiness failure impacting MIC results or conflicting panels.
- AI action
- AI monitors run status and alerts if results diverge from expected panel profiles.
- 4
MIC microdilution panels
- Watch for
- Antibiotic panel errors, sample mix-ups, or low growth leading to unreliable MIC values.
- AI action
- AI cross-checks MIC values against historical patterns and flags anomalies.
- 5
LIS (Laboratory Information System)
- Watch for
- Mismatched patient identifiers or result reconciliation gaps between lab and EHR.
- AI action
- AI enforces strict matching, auto-displays result tie-back to case discharge dossier.
- 6
Biosafety cabinet Class II
- Watch for
- Filter wear or airflow disruption increasing contamination risk and personnel exposure.
- AI action
- AI triggers maintenance if airflow or filter integrity readings breach thresholds.
Worked example
Catching resistance signals in canine wound infections
Illustrative scenario with sample data.
A 5-year-old dog with a chronic wound yields bacterial culture; AI flags resistance markers and recommends targeted therapy.
Signal in
order_id: 93827; species: Canis lupus familiaris; wound_site: left hindlimb; culture_date: 2026-11-01; organism: Staphylococcus pseudintermedius; initial_Antibiotic: amoxicillin-clavulanate; MICs: oxacillin >2, clindamycin 0.25, cephalexin 16
System out
report_id: RPT-12045; organism_ident: Staphylococcus pseudintermedius; resistance: oxacillin resistant; susceptible: clindamycin; output: targeted therapy suggested; flag: MDR concern.
Human sign-off: Clinical microbiologist reviews AI flags, confirms oxacillin resistance, approves clindamycin guidance and updates the antimicrobial stewardship note.
How to roll it out
Phase 1
Weeks 1 to 4
Baseline data model and hospital information interfaces configured; initial validation with historical culture results.
Phase 2
Weeks 5 to 8
Pilot AI reporting on a subset of cases with clinician feedback loops and audit logging.
Phase 3
Weeks 9 to 12
Full integration with LIS; standard operating procedures approved; governance sign-off recorded.
Where people stay in charge
- Decisions on patient treatment based on AI output remain under the clinician or microbiologist's final authority.
- All antimicrobial recommendations must be reviewed and signed by the attending veterinarian or clinical microbiologist.
- Critical result overrides and MDR identifications require explicit approval by the Radiation Protection Supervisor or equivalent.
Questions owners and crews ask
How does AI help with culture result interpretation in a veterinary lab?
AI assists by standardising result fields, flagging unusual patterns, and proposing panel selections, while the clinician retains final interpretation and discharge decision.
What happens when a result is flagged as MDR or unusual resistance?
AI flags the pattern, cross-checks historical data, prompts confirmatory tests, and notifies the antimicrobial stewardship lead for review and action.
Who signs off on antimicrobial recommendations generated by AI?
The attending veterinarian or board-certified microbiologist reviews and signs off before case discharge or therapy changes.
Can this system integrate with referral notes and case discharge documents?
Yes, AI outputs are linked to the patient record, and can populate referral letters and case discharge summaries within the LIS.